BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Feinstein Kean Healthcare, Inc. 

245 First Street, 14th Floor

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-577-8110 Fax: 617-577-8985


SEARCH JOBS




Industry
Services






 Company News
Feinstein Kean Healthcare, Inc. Release: Robert Finn Named Executive Editor of Multiple Sclerosis Discovery Forum for ACP 7/9/2013 6:38:37 AM    More...
Alfacell (ACEL) Selects TS Communications And Feinstein Kean Healthcare, Inc. For Comprehensive Integrated Communications 9/18/2006 12:18:43 PM    More...
Janssen Pharmaceutica Products, L.P. And Feinstein Kean Healthcare Release: RISPERDAL (risperidone) Shown To Rapidly Reduce Manic Symptoms Associated With Bipolar Disorder 10/19/2005 5:11:35 PM    More...
ANZACC: Scientists From Australia And New Zealand Discuss Stem Cell Research And Clinical Trials At 3rd Annual Conference In Cambridge, Massachusetts 10/19/2005 5:11:29 PM    More...
Feinstein Kean Healthcare Expands Creative Services To Meet Client Demand 10/19/2005 5:11:16 PM    More...
Janssen Pharmaceutica Products, L.P. Release: Risperdal Consta Improves Symptom Control In Many People With Schizophrenia 10/19/2005 5:11:12 PM    More...
Janssen Pharmaceutica Products, L.P. Release: Many Stabilized, Young Adults With Schizophrenia May Benefit From Early Treatment With Risperdal 10/19/2005 5:11:12 PM    More...
Feinstein Kean Healthcare, Inc.'s Rebranding Campaign For Nabi Biopharmaceuticals (NABI) Wins 2005 ReBrand 100(TM) Award 10/19/2005 5:09:07 PM    More...
Feinstein Kean Healthcare Release: New Office-Based Treatment For Prescription Drug And Heroin Addiction 10/19/2005 5:08:57 PM    More...